PCR Role in Screening & Diagnostics Discussed by Biopharm Reports in New Market Study Available at MarketPublishers.com Business Wire LONDON -- June 3, 2013 Polymerase chain reaction (PCR) technology is widely utilised in the molecular biology field, including a variety of applications such as sequencing, DNA fingerprinting, cloning, infectious diseases molecular testing, research, drug RnD, disease biomarkers, gene expression, forensics, among others. The technique’s growing popularity is expected to drive the global market to a value of USD27bn by end-2015. Furthermore, a constant rise in the number of patients afflicted with cancer, AIDS and hepatitis, as well as huge investments into medical research also contribute to the market expansion. Different PCR techniques available in the market today include reverse transcription PCR (RTPCR), quantitative PCR (qPCR), inverse PCR, assembly PCR (polymerase cycling assembly, PCA), allele specific PCR, multiplex PCR, taqman, nested PCR, among others. Abbott Laboratories, Agilent Technologies, Beckman Coulter Inc., Affymetrix Inc., Roche, Sigma-Aldrich Corp., Becton, Dickinson and Co. (BD), and GE Healthcare are some of the dominant players in the world PCR field. New market study “PCR in Screening and Diagnostics: Market Developments, Growth Areas and Opportunities” created by Biopharm Reports examines the use of PCR in screening and diagnostics worldwide. The report investigates key market developments, and identifies new insights and opportunities in the marketplace during 2013-2016. In particular, it analyses current and future anticipatedtechniques and applications, end-users’ plans for using PCR in screening and diagnostics in the forecast period, as well as preferred products, purchasing and new developments. Additionally, the research covers new and emerging applications, end-users’ preferred PCR instruments and their strengths and weaknesses, current and future expenditure and financial budgets, budget breakdown, average costs per sample, innovation, quality control guidelines or procedures used in PCR analysis, consumables, bioinformatics software, and sample preparation. Report Details: Title: PCR in Screening and Diagnostics: Market Developments, Growth Areas and Opportunities Published: June, 2013 Pages: 168 Price: US$ 2,794.00 http://marketpublishers.com/report/life_sciences/healthcare/pcr-in-screening-n-diagnostics-market-developments-growth-areas-n-opportunities.html Report Contents: CHAPTER 1 INTRODUCTION CHAPTER 2 STUDY PARTICIPANTS 2.1 This Chapter 2.2 Countries 2.3 Regions 2.4 Organisation Types 2.5 Fields 2.6 PCR Activities 2.7 Participants 2.8 Discussion Figure 2.1 Countries of individuals who participated in PCR 2013 CLIN ... More new studies by Biopharm Reports can be found at http://marketpublishers.com/members/biopharm_reports/info.html Contact: The Market Publishers, Ltd. Tanya Rezler Tel: +44 208 144 6009 Fax: +44 207 900 3970 email@example.com MarketPublishers.com
PCR Role in Screening & Diagnostics Discussed by Biopharm Reports in New Market Study Available at MarketPublishers.com
Press spacebar to pause and continue. Press esc to stop.